Login / Signup
Industries
Technology
Energy
Media
Finance
Green Issues
China
All Concepts
Metals
Energy
Meats
Grains
Softs
ETFs
Indices
Currencies
Geographies
Exchanges
Rates
How To Invest
Personal Finance
Options 101
Definitions
close
close
Send us Feedback
Progen Pharmaceuticals (PGLA)
SUMMARY
BULLS
BEARS
DATA CENTRAL
STOCK CHART
BALANCE SHEET
INCOME STMT
CASH FLOW
Key Metrics for PGLA as compared to
Top Competitors
Medical Laboratories & Research
Pharma & healthcare
All values TTM unless otherwise noted (*)
INDUSTRY METRICS (
See all
)
Revenue
►
1.04M
AVG
Revenue
INCOME STATEMENT (
See all
)
Revenue
►
1.04M
AVG
EBITDA
►
-24.6M
AVG
Net Income
►
-25.1M
AVG
Revenue Growth
►
44%
AVG
Operating Margin
►
-2161.8%
AVG
Net Margin
►
-2408.4%
AVG
Revenue, Gross Profit, and Gross Margin
Operating Expenses
Research & Development
SG&A
Amortization & Depreciation
BALANCE SHEET (most recent quarter) (
See all
)
Debt / Equity
►
0.0974
AVG
Current Ratio
►
11.0
AVG
Quick Ratio
►
11.0
AVG
Interest Coverage Ratio
►
-1K
AVG
Book Value Per Share
►
1.20
Cash Per Share
►
0.0199
Loading...
STOCK SUMMARY
Open
0.44
Day Range
0.45
-
0.45
52 Week Range
0.30
-
0.80
Volume
3K
Avg Volume (3 mo)
4K
Shares Outstanding
64.8M
Market Cap
28.5M
VALUATION
Price to Earnings (P/E)
►
-1.32
Price to Book (P/B)
►
0.457
AVG
Price to Sales (P/S)
►
31.7
AVG
Return on Assets (ROA)
►
-30.4%
AVG
Return on Equity (ROE)
►
-32.3%
AVG
EV/EBITDA
►
-1.39
Dividend Yield
0%
AVG
OWNERSHIP
Held by institutions
0.2%
No Sales Breakout Data.